These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36380732)

  • 1. α-Synuclein Disrupts Vesicle Fusion by Two Mutant-Specific Mechanisms.
    Yoo G; An HJ; Yeou S; Lee NK
    Mol Cells; 2022 Nov; 45(11):806-819. PubMed ID: 36380732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.
    Lima VA; do Nascimento LA; Eliezer D; Follmer C
    ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates.
    Wang C; Zhang K; Cai B; Haller JE; Carnazza KE; Hu J; Zhao C; Tian Z; Hu X; Hall D; Qiang J; Hou S; Liu Z; Gu J; Zhang Y; Seroogy KB; Burré J; Fang Y; Liu C; Brunger AT; Li D; Diao J
    Nat Cell Biol; 2024 Aug; 26(8):1287-1295. PubMed ID: 38951706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
    Choong CJ; Say YH
    Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
    Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
    Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
    J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free detection of early oligomerization of α-synuclein and its mutants A30P/E46K through solid-state nanopores.
    Li X; Tong X; Lu W; Yu D; Diao J; Zhao Q
    Nanoscale; 2019 Mar; 11(13):6480-6488. PubMed ID: 30892349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors.
    Wislet-Gendebien S; Visanji NP; Whitehead SN; Marsilio D; Hou W; Figeys D; Fraser PE; Bennett SA; Tandon A
    BMC Neurosci; 2008 Sep; 9():92. PubMed ID: 18808659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling.
    Sun J; Wang L; Bao H; Premi S; Das U; Chapman ER; Roy S
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11113-11115. PubMed ID: 31110017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
    Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
    J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo.
    Mbefo MK; Fares MB; Paleologou K; Oueslati A; Yin G; Tenreiro S; Pinto M; Outeiro T; Zweckstetter M; Masliah E; Lashuel HA
    J Biol Chem; 2015 Apr; 290(15):9412-27. PubMed ID: 25657004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
    Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
    Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
    J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking.
    Lou X; Kim J; Hawk BJ; Shin YK
    Biochem J; 2017 Jun; 474(12):2039-2049. PubMed ID: 28495859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral lysophosphatidylcholine mediates α-synuclein-induced synaptic vesicle clustering.
    Lai Y; Zhao C; Tian Z; Wang C; Fan J; Hu X; Tu J; Li T; Leitz J; Pfuetzner RA; Liu Z; Zhang S; Su Z; Burré J; Li D; Südhof TC; Zhu ZJ; Liu C; Brunger AT; Diao J
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310174120. PubMed ID: 37883437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative inhibition of SNARE-mediated vesicle fusion by α-synuclein monomers and oligomers.
    Yoo G; Yeou S; Son JB; Shin YK; Lee NK
    Sci Rep; 2021 May; 11(1):10955. PubMed ID: 34040104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive assay reveals structural requirements for α-synuclein fibril growth.
    Dhavale DD; Tsai C; Bagchi DP; Engel LA; Sarezky J; Kotzbauer PT
    J Biol Chem; 2017 Jun; 292(22):9034-9050. PubMed ID: 28373279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.